[VRTX] YoY Quarter Result on 30-Sep-2011 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
03-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- 227.02%
YoY- 205.82%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 178,987 221,700 336,006 659,200 23,795 24,957 31,609 33.48%
PBT -166,577 -129,406 -5,112 200,610 -208,957 -149,565 -130,044 4.21%
Tax 3,419 -751 21,355 -27,842 3,477 -4,709 301 49.90%
NP -170,060 -124,125 -57,543 221,110 -208,957 -149,565 -130,044 4.57%
Tax Rate - - - 13.88% - - - -
Total Cost 349,047 345,825 393,549 438,090 232,752 174,522 161,653 13.68%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin -95.01 -55.99 -17.13 33.54 -878.16 -599.29 -411.41 -21.66%
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
EPS -0.72 -0.54 -0.27 1.06 -1.04 -0.84 -0.93 -4.17%
EPS Diluted -0.72 -0.54 -0.27 1.02 -1.04 -0.84 -0.93 -4.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.